Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Transdermal Lidocaine Patch for Post-Cesarean Pain in Women With Obesity
NCT03810235Phase 4Completed
- Sponsor
- University of Wisconsin–Madison
- Start
- Feb 2019
- Primary completion
- Sep 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of lidocaine 10% oropharyngeal spray in postoperative pain (2 arms), sponsored by University of Wisconsin–Madison. Primary endpoint: Total Dose of Opioids Received in the First 24 Hours Following Cesarean. Started Feb 2019; status: completed.
02
Drugs
lidocaine 10% oropharyngeal spray
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT03810235.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03810235.